Combination drug treatment of beingn prostatic hyperplasia (BPH)

Citation:
OLIECH JS. "Combination drug treatment of beingn prostatic hyperplasia (BPH).". In: The Annals of African Surgery. PROF.J.S.OLIECH; 2010.

Abstract:

Combination use of alpha-adrenergic blockers (tamsulocin or alfuzocin) and 5 alpha iso-enzyme 1&2 inhibitor (dutasteride) in symptomatic benign prostatic hyperplasia (BPH) is the best first optional mode of treatment giving good results with minimal treatment  adverse effects especially for those at risk for surgical intervention and those who are still sexually active. 

Notes:

n/a

Website

UoN Websites Search